• CRISPR Therapeutics' (CRSP) "Market Outperform" Rating Reaffirmed at JMP Securities

    Источник: Buzz FX / 20 дек 2024 09:17:11   America/New_York


    CRISPR Therapeutics' (CRSP) "Market Outperform" Rating Reaffirmed at JMP Securities Written by MarketBeat December 20, 2024 Share Link copied to clipboard. CRISPR Therapeutics ( NASDAQ:CRSP - Get Free Report ) 's stock had its "market outpe
    Read more...
Опубликовать